Suchergebnisse - "Sarilumab"

PubPharm (19)

1

Effectiveness and safety of sarilumab in patients with rheumatoid arthritis : A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry

enthalten in: Clinical rheumatology | 2024

von Harada, H. | Kondo, M. | Maeyama, A. | +8

ErratumIn: Clin Rheumatol. 2024 Mar 15;:. - PMID 38489137

2

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

3

Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels

enthalten in: Joint bone spine | 2022

von Marotte, H. | Fakra, E. | Flipo, R. | +4

4

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis : results from post hoc analyses of three phase III trials of sarilumab

enthalten in: Arthritis research & therapy | 2022

von Rubbert-Roth, A. | Furst, D. | Fiore, S. | +5

5

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis : the ANSWER cohort study

enthalten in: Clinical rheumatology | 2021

von Ebina, K. | Hirano, T. | Maeda, Y. | +16

6

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

enthalten in: Arthritis research & therapy | 2020

von Strand, V. | Boklage, S. | Kimura, T. | +3

7

Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis

enthalten in: Reumatologia clinica | 2020

von Tornero Molina, J. | Balsa Criado, A. | Blanco García, F. | +7

8

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

enthalten in: Arthritis research & therapy | 2020

von Genovese, M. | Fleischmann, R. | Kivitz, A. | +6

9

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

enthalten in: Arthritis research & therapy | 2020

von Gabay, C. | Burmester, G. | Strand, V. | +8

10

Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis : A Japan phase 3 trial (HARUKA)

enthalten in: Modern rheumatology | 2020

von Kameda, H. | Wada, K. | Takahashi, Y. | +4